FT. LAUDERDALE, FL--(MARKET WIRE)--Aug 8, 2008 -- OmniComm Systems, Inc. (OTC BB:OMCM.OB - News), a leader in integrated electronic data capture (EDC) solutions for clinical trials, today announced that several of their key executives have been asked to conduct sessions on the benefits of electronic data capture and the use of effective implementation methods to maximize the potential benefits of using EDC. The sessions will be held at two of the industry's premier meetings, The Data Monitoring Committees Conference in August in Philadelphia and the Society for Clinical Data Management Fall Conference in September in Dallas.

Session Information:

 
    CBI's Symposium on Data Monitoring Committees
    August 13-14, 2008 in Philadelphia, PA
    Ken Light, Senior VP of Professional Services, OmniComm Systems, Inc.
    "Electronic Data Capture to Streamline the DMC Process - Benefits
    and Challenge"
    Thursday, August 14, 2008 11:00 - 11:30 AM

    Society for Clinical Data Management
    September 21-23, 2008 in Dallas, TX
    Sondra Smyrnios, Senior VP Clinical Operations, OmniComm Systems, Inc.
    "Balancing the Benefits of EDC: Speed, Quality, and Cost"
    Monday, September 22, 2008 from 1:30 PM - 3:00 PM

    Colleen Lockwood, Client Services and Training, OmniComm Systems, Inc.
    "How to Successfully Convert a Traditional Data Management Department
    to an EDC Data Management Department"
    Tuesday, September 23, 2008 from 10:30 AM - 12:00 PM

About OmniComm

OmniComm Systems, Inc. (www.OmniComm.com) provides customer-driven Internet solutions to pharmaceutical, biotechnology, research and medical device organizations that conduct life changing clinical trial research. OmniComm's growing base of satisfied customers is a direct result of the company's commitment to deliver products and services that ensure ease of use, faster study build, ease of integration and better performance. OmniComm's client intuitive pricing model allows companies that range from small to mid-size to large scale institutions to safely and efficiently capitalize on their clinical research investments. OmniComm Systems, Inc. has corporate headquarters in Ft. Lauderdale, Florida with offices in Bonn, Germany, Tula, Russia, California, Maryland, New York, North Carolina and Texas.

Safe Harbor Disclaimer

Statements about OmniComm's future expectations, including without limitation, future revenues and earnings, plans and objectives for the future operations, future agreements, future economic performance, operations and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. OmniComm intends that such forward-looking statements be subject to the Safe Harbors created thereby. Since these statements involve risks and uncertainties, including but not limited to economic competitive, governmental, contractual and technological factors affecting OmniComm's operations, markets and profitability, actual results could differ materially and adversely from the expected results.

     CONTACT:
     Lizanne Kelley
     OmniComm Systems, Inc.
     954-473-1254 Extension 283
     Email Contact